The first patient to receive the Russian cancer vaccine has disappeared. For about four months, the doctors did not recognize the neoplasms in him, said in an interview with Gazeta.ru, the scientific director of the Gamali Center Alexander Ginzburg. The patient was treated for melanoma with a customized RNA vaccine Neonkovak. The course of treatment has been completed, but doctors will continue to monitor his condition for three years.